Search results for akt3

Anti-AKT1 + AKT2 + AKT3 antibody [EPR16798], Abcam, AB179463

What is this antibody validated in? Anti-AKT1 + AKT2 + AKT3 antibody [EPR16798] (ab179463) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat, Xenopus laevis, Xenopus tropicalis samples. What is the molecular weight of AKT1 + AKT2 + AKT3? Anti-AKT1 + AKT2 + AKT3 [EPR16798] (ab179463) specifically detects a band for AKT1 + AKT2 + AKT3 (UniProt: P31749) at a molecular weight of 56kDa. Trusted by the scientific community Anti-AKT1 + AKT2 + AKT3 [EPR16798] (ab179463) was first used in a scientific publication in 2014 and has been cited over 310 times in peer-reviewed journals. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Other related products We have a range of other formats of antibody clone [EPR16798] also available for your convenience: ab179463, PE - ab210454 , Carrier free - ab214167 , Carrier free - ab271930 , Alexa Fluor® 647 - ab302553 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671], Abcam, AB185633

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737], Abcam, AB200195

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-AKT3 + AKT2 + AKT1 antibody [RM1043], Abcam, AB300473

Anti-AKT3 + AKT2 + AKT1 antibody [Y89], Abcam, AB32505

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

AKT1/AKT2/AKT3 Rabbit pAb- ABclonal, ABclonal, A24477

HRP Anti-AKT1 + AKT2 + AKT3 antibody [EPR16798], Abcam, AB200854

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

AKT1 / AKT2 / AKT3 (pY315 / 316 / 312) Antibody, Abbexa, abx333213

AKT1/AKT2/AKT3 (pY315/316/312) Antibody is a Rabbit Polyclonal against AKT1/AKT2/AKT3 (pY315/316/312).

PE Anti-AKT3 + AKT2 + AKT1 antibody [Y89], Abcam, AB316178

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

RAC-Gamma Serine/threonine-Protein Kinase (AKT3) Antibody, Abbexa, abx033131

AKT3 is a member of the AKT, also called PKB, serine/threonine protein kinase family. AKT kinases are known to be regulators of cell signaling in response to insulin and growth factors. They are involved in a wide variety of biological processes including cell proliferation, differentiation, apoptosis, tumorigenesis, as well as glycogen synthesis and glucose uptake. This kinase has been shown to be stimulated by platelet-derived growth factor (PDGF), insulin, and insulin-like growth factor 1 (IGF1).